ArticleBMC pregnancy and childbirth2026
Prevalence and associated factors of chorioamnionitis among women with preterm premature rupture of membranes at Mbarara Regional Referral Hospital, Southwestern Uganda.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChorioamnionitis is a frequent complication of preterm premature rupture of membranes (PPROM) and contributes substantially to adverse maternal and neonatal outcomes. However, data on the burden and determinants of chorioamnionitis among women with PPROM in resource-limited settings, including Uganda, are limited. This study determined the prevalence and factors associated with chorioamnionitis among women admitted with PPROM at a regional referral hospital in southwestern Uganda.
methodsThis hospital-based cross-sectional study was conducted from December 2024 to April 2025 among pregnant women admitted at 26 weeks to 36 weeks and 6 days of gestation, with a diagnosis of PPROM. Consecutive sampling was used to enroll participants. Data were obtained through structured interviews, review of clinical records, and laboratory investigations, including microbiological culture, to capture sociodemographic, obstetric, medical, and clinical information. Chorioamnionitis was defined as maternal fever (≥ 38 °C) with at least one additional clinical or laboratory sign (uterine tenderness, foul-smelling amniotic fluid, maternal or fetal tachycardia, leukocytosis, or elevated C-reactive protein) and a positive cervical or posterior fornix culture used to detect intra-amniotic infection. Associations were assessed using modified Poisson regression to estimate adjusted prevalence ratios (aPRs) with 95% confidence intervals.
resultsA total of 324 women were enrolled with a mean age of 26.56 (± 5.86) years. Most of the women had primary or no education (69.8%), and were unemployed (65.7%). The prevalence of chorioamnionitis was 39.8% (n = 129/324, 95% Confidence Interval [CI]: 34.6–45.3%). The factors independently associated with chorioamnionitis were duration of PPROM (≥ 4 days) (aPR = 5.85, 95% CI: 2.68–12.78) and undergoing ≥ 4 digital vaginal examinations (aPR = 3.25, 95% CI: 1.51–6.70).
conclusionChorioamnionitis was common, affecting approximately four in ten women with PPROM at MRRH, which may be influenced by delayed presentation and initiation of prophylactic antibiotics. Prolonged duration of membrane rupture and multiple digital vaginal examinations were associated with increased prevalence of chorioamnionitis. These findings underscore the importance of preventive practices during expectant management of PPROM, including minimizing unnecessary digital vaginal examinations and maintaining clinical vigilance for signs of chorioamnionitis. Future studies could evaluate the maternal and perinatal outcomes of chorioamnionitis among women with PPROM in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.